BD is one of the top suppliers of prefilled syringes to the pharma industry, with more than a billion UltraSafePlus devices used in around 40 different products since it was first launched in 2010.

SMi are pleased to present the 12 th Annual Pre-Filled Syringes and Injectable Drug Devices conference in London on 15 th and 16 th January 2020. As Europe’s leading Pre-Filled Syringes ...

Once the new lines are fully operational, BD’s domestic manufacturing capacity of injection devices will increase by more than 40%, and production of conventional syringes will increase by more ...

is increasing its U.S. manufacturing capacity for essential medical devices ... new production lines for needles and syringes have been installed at BD's plants in Connecticut and Nebraska ...

These new lines will boost BD's capacity of domestically manufactured safety-engineered injection devices by more than 40 percent and conventional syringes by more than 50 percent, adding hundreds ...

Focus on Patient Safety and Convenience Prefilled syringes minimize contamination risks and reduce preparation time, making them ideal for both healthcare settings and self-administration by patients ...

FRANKLIN LAKES, N.J., Jan. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced additional investments in its U.S.

All nurses should be re-oriented to use the Carpuject prefilled syringes as intended by the manufacturer, and to ensure understanding of the risks associated with using the cartridges as vials.

Most participating nurses (87%) worked in organizations that have been using Carpuject prefilled syringe cartridges for more than 2 years. When preparing a Carpuject syringe, 8% of nurses told us ...